A Single-centre, Open-label, Randomised, Crossover, Drug-drug Interaction Study in Healthy Men to Investigate the Effect of a Single Dose of ASP2151 on the Pharmacokinetics of Montelukast
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2015
At a glance
- Drugs Amenamevir (Primary) ; Montelukast
- Indications Herpes simplex virus infections; Herpes zoster
- Focus Pharmacokinetics
- Sponsors Maruho
- 17 Aug 2015 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 05 Jun 2015 Planned End Date changed from 1 Apr 2015 to 1 Sep 2015, according to to ClinicalTrials.gov record.
- 05 Jun 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Jun 2015, according to to ClinicalTrials.gov record.